Emi Honda

432 total citations
15 papers, 342 citations indexed

About

Emi Honda is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emi Honda has authored 15 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emi Honda's work include Fibroblast Growth Factor Research (5 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Medical Imaging and Pathology Studies (3 papers). Emi Honda is often cited by papers focused on Fibroblast Growth Factor Research (5 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Medical Imaging and Pathology Studies (3 papers). Emi Honda collaborates with scholars based in Japan, Malaysia and United States. Emi Honda's co-authors include Masahiro Asada, Toru Imamura, Masashi Suzuki, Junko Oki, Masahiko Ikekita, Yuko Oda, Ryohei Nakayama, H. Koyama, Yuka Tanaka and Motoaki Shiratsuchi and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Analytical Biochemistry.

In The Last Decade

Emi Honda

12 papers receiving 331 citations

Peers

Emi Honda
Tod A. Brown United States
Tamara Ouspenskaia United States
Penelope Marr Australia
Wendy Kennedy United Kingdom
N Groult France
Horace Rhee United States
Tod A. Brown United States
Emi Honda
Citations per year, relative to Emi Honda Emi Honda (= 1×) peers Tod A. Brown

Countries citing papers authored by Emi Honda

Since Specialization
Citations

This map shows the geographic impact of Emi Honda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Honda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Honda more than expected).

Fields of papers citing papers by Emi Honda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Honda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Honda. The network helps show where Emi Honda may publish in the future.

Co-authorship network of co-authors of Emi Honda

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Honda. A scholar is included among the top collaborators of Emi Honda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Honda. Emi Honda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
3.
Honda, Emi, et al.. (2015). Computer-Aided Diagnosis Scheme for Distinguishing Between Benign and Malignant Masses in Breast DCE-MRI. Journal of Digital Imaging. 29(3). 388–393. 22 indexed citations
4.
Okudela, Koji, Shigeaki Umeda, Emi Honda, et al.. (2014). A case of pulmonary hamartoma with distinctive histopathological features: A discussion of its differential diagnosis and histogenesis. Pathology International. 64(12). 618–623. 6 indexed citations
5.
Honda, Emi, et al.. (2013). Imatinib induces demethylation of miR-203 gene: An epigenetic mechanism of anti-tumor effect of imatinib. Leukemia Research. 37(10). 1278–1286. 39 indexed citations
6.
Umemura, Tsukuru, et al.. (2013). An Epigenetic Mechanism Of Imatinib Via Demethylation Of MiR-203. Blood. 122(21). 3766–3766.
7.
Oda, Yuko, Junko Oki, Emi Honda, et al.. (2012). Hair Cycle Resting Phase Is Regulated by Cyclic Epithelial FGF18 Signaling. Journal of Investigative Dermatology. 132(5). 1338–1345. 103 indexed citations
8.
Imamura, Toru, Yuko Oda, Junko Oki, et al.. (2012). Telogen Phase of Hair Growth Cycle Is Regulated by Cyclic Epithelial FGF18 Signaling. Journal of Dermatological Science. 69(2). e64–e65.
9.
Nakamura, Masao, Yuriko Uehara, Masahiro Asada, et al.. (2011). Sulfated Glycosaminoglycans Are Required for Specific and Sensitive Fibroblast Growth Factor (FGF) 19 Signaling via FGF Receptor 4 and betaKlotho. Journal of Biological Chemistry. 286(30). 26418–26423. 22 indexed citations
10.
Shiratsuchi, Motoaki, et al.. (2011). [Successful treatment with immunosuppressive therapy for aplastic anemia developed after resection of thymoma].. PubMed. 52(5). 293–8. 2 indexed citations
11.
Motomura, Kaori, Akiko Hagiwara, Yoshiro Hanyu, et al.. (2008). An FGF1:FGF2 chimeric growth factor exhibits universal FGF receptor specificity, enhanced stability and augmented activity useful for epithelial proliferation and radioprotection. Biochimica et Biophysica Acta (BBA) - General Subjects. 1780(12). 1432–1440. 37 indexed citations
12.
Asada, Masahiro, Emi Honda, & Toru Imamura. (2008). Biologically active fibroblast growth factor 1 tagged with various epitopes. BMC Research Notes. 1(1). 42–42. 1 indexed citations
13.
Asada, Masahiro, et al.. (2008). Glycosaminoglycan affinity of the complete fibroblast growth factor family. Biochimica et Biophysica Acta (BBA) - General Subjects. 1790(1). 40–48. 96 indexed citations
14.
Asada, Masahiro, Emi Honda, & Toru Imamura. (2006). Construction of pcDNA3.1-based vectors with blasticidin and puromycin resistance markers. Analytical Biochemistry. 352(2). 305–307. 5 indexed citations
15.
Nakamura, Hideki, Emi Honda, Nozomi Iwanaga, et al.. (2006). Tacrolimus as a reinforcement therapy for a patient with MPO-ANCA-associated diffuse alveolar hemorrhage. Clinical Rheumatology. 26(7). 1211–1214. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026